AbbVie Inc., the global research-driven biopharmaceutical powerhouse, was spun off from Abbott Laboratories on January 1, 2013. Richard A. Gonzalez served as its founding Chairman and Chief Executive Officer from inception through July 1, 2024, building AbbVie into one of the largest pharmaceutical companies in the world. Under Gonzalez’s leadership, AbbVie’s market capitalization grew from $54 billion to over $300 billion, revenue nearly tripled, and the company delivered a more than 700% total return to shareholders. A pharma industry veteran with over 30 years of experience, Gonzalez guided AbbVie through the rise and fall of the blockbuster drug Humira and positioned the company for long-term growth through strategic acquisitions and pipeline development.

(Suggested: Pfizer CEO Email & Net Worth – Albert Bourla Salary)

Richard Gonzalez – Quick Facts

AbbVie Competitors

Under Richard Gonzalez’s leadership, AbbVie competed at the highest levels of the global pharmaceutical industry. Key competitors of AbbVie include:

• Pfizer – global pharma leader with $63.6B in FY2024 revenue
• Merck & Co. – immunology and oncology competitor ($64.2B revenue)
• Johnson & Johnson – diversified healthcare giant ($57.1B pharma revenue)
• Eli Lilly – fast-growing immunology and GLP-1 rival
• Roche / Genentech – oncology and biologics competitor
• AstraZeneca – immunology and oncology ($54.1B revenue)
• Gilead Sciences – virology and oncology competitor
• Amgen – biosimilar and inflammation competitor

Richard Gonzalez Net Worth 2026 – AbbVie CEO Salary

As of 2026, Richard Gonzalez’s net worth is estimated at approximately $120–410 million USD, based on his disclosed AbbVie stock holdings and SEC filings. According to GuruFocus, Gonzalez owns approximately 446,599 shares of AbbVie stock worth over $100 million. In 2024 alone, he cashed out 891,250 shares for over $106 million. Various sources provide estimates ranging from $123 million (GuruFocus) to $412 million (Benzinga), reflecting differences in how total lifetime compensation and stock gains are calculated.

AbbVie CEO Compensation Breakdown (2023 – Final Full Year as CEO)

AbbVie Net Worth 2026 – Is AbbVie Profitable?

Yes, AbbVie is a highly profitable company. During Richard Gonzalez’s tenure, AbbVie grew from a $54 billion company to one valued at over $400 billion. In fiscal year 2025, AbbVie reported record net revenues of $61.16 billion, demonstrating resilience despite the loss of Humira’s U.S. exclusivity in 2023.

AbbVie Financial Summary (FY2025 vs. FY2024)

(Recommended: Eli Lilly CEO Email & Net Worth – Dave Ricks Salary)

AbbVie CEO Email Address | Richard Gonzalez Contact

Below are the contact details and social media profiles for former AbbVie CEO Richard Gonzalez. Note that as he has retired from the company, some corporate contact channels may no longer be active:

Career & Education – Company, University, & College

Richard Gonzalez’s career spans more than three decades in the pharmaceutical industry, almost entirely with Abbott Laboratories and its spinoff AbbVie. Below is his complete career timeline:

Richard Gonzalez Career Timeline

Richard Gonzalez began his career at Abbott Laboratories in the 1970s, where he spent over three decades rising through the ranks. He held key executive positions including Divisional Vice President and General Manager of Abbott Diagnostics, Executive Vice President of the Pharmaceutical Products Group, and ultimately President and Chief Operating Officer of the entire company.

In 2007, Gonzalez was diagnosed with throat cancer and temporarily retired from Abbott. During his two-year retirement, he played golf but grew restless. After making a full recovery, he returned to Abbott in 2009 as President of Abbott Ventures, the company’s investment arm.

When Abbott decided to spin off its pharmaceutical division, Gonzalez was chosen to lead the new company. He became the founding Chairman and CEO of AbbVie when it launched as an independent publicly traded company on January 1, 2013. He led AbbVie for over 11 years, stepping down as CEO on July 1, 2024 and continuing as Executive Chairman until July 2025.

(Related: Merck CEO Email & Net Worth – Robert Davis Salary)

Education

Richard Gonzalez’s educational background became a matter of public scrutiny in 2012 when Crain’s Chicago Business reported that he did not hold the university degrees previously listed in Abbott’s SEC filings. Records showed that Gonzalez attended the University of Houston from fall 1972 to fall 1973 and briefly attended the University of Miami in early 1974, but did not complete degrees at either institution. He later completed an Advanced Management Program at Harvard Business School.

Richard Gonzalez Wiki – Age, Family, & More

Richard A. Gonzalez (age 72, born January 21, 1954) is an American business executive who led AbbVie from its founding through over a decade of transformative growth. He married Chantel Gia Poynton, a jewelry designer, at the Versace Mansion (Barton G Villa) in Miami on May 16, 2015. The couple has a daughter, born on July 26, 2013. Gonzalez keeps his personal and family life relatively private.

One of the defining personal moments in Gonzalez’s career came in 2007 when he was diagnosed with throat cancer while serving as COO of Abbott Laboratories. He retired to focus on treatment and recovery. After two years away, during which he played golf and grew “bored” with retirement, he returned to the pharmaceutical industry upon his full recovery, ultimately leading the creation of AbbVie.

Notable Achievements & Legacy

• Founding CEO of AbbVie – Led the $54 billion spin-off from Abbott Laboratories in 2013 and built it into a $300+ billion company
• 700%+ Shareholder Return – Delivered one of the strongest total returns among large-cap pharma companies during his tenure
• Humira Commercialization – Oversaw the world’s best-selling drug, which peaked at $21 billion in annual sales and generated over $200 billion in cumulative revenue
• $63 Billion Allergan Acquisition (2019) – Led AbbVie’s largest deal, acquiring the Botox maker to diversify beyond Humira
• $21 Billion Pharmacyclics Acquisition (2015) – Secured the cancer drug Imbruvica
• $250 Billion in R&D Investment – Invested heavily in pipeline development including Skyrizi and Rinvoq, AbbVie’s next-generation immunology blockbusters
• Congressional Testimony – Testified multiple times before Congress defending pharmaceutical pricing practices
• Cancer Survivor – Returned to lead a Fortune 500 company after defeating throat cancer

(Suggested: Abbott CEO Email & Net Worth – Miles White)

About AbbVie Inc.

AbbVie Inc. is a global, research-driven biopharmaceutical company headquartered in North Chicago, Illinois. Spun off from Abbott Laboratories on January 1, 2013, AbbVie has grown into one of the largest pharmaceutical companies in the world, with $61.16 billion in net revenue for fiscal year 2025 and approximately 57,000 employees worldwide.

AbbVie trades on the New York Stock Exchange under the ticker symbol ABBV. As of early 2026, the company has a market capitalization of approximately $404 billion, making it one of the most valuable pharmaceutical companies in the world.

Frequently Asked Questions (FAQ)

Who is Richard Gonzalez?

Richard A. Gonzalez (born January 21, 1954) is an American pharmaceutical executive who served as the founding Chairman and CEO of AbbVie Inc. from its spin-off from Abbott Laboratories in January 2013 until July 2024. He then served as Executive Chairman until July 2025. Under his leadership, AbbVie grew from a $54 billion company to one worth over $300 billion.

What is Richard Gonzalez’s net worth in 2026?

As of 2026, Richard Gonzalez’s net worth is estimated at $120–410 million USD. He owns approximately 446,599 shares of AbbVie stock worth over $100 million. In 2024, he sold 891,250 shares for over $106 million. Estimates vary by source depending on how lifetime compensation and stock gains are calculated.

Is Richard Gonzalez still CEO of AbbVie?

No. Richard Gonzalez retired as CEO of AbbVie on July 1, 2024, and was succeeded by Robert A. Michael, who had served as President and COO. Gonzalez continued as Executive Chairman until July 2025, when he fully departed from AbbVie’s board of directors.

What was Richard Gonzalez’s salary as AbbVie CEO?

In his final full year as CEO (2023), Richard Gonzalez earned approximately $25.7 million in total compensation, including a $1.7 million base salary, $3.5 million bonus, $13.7 million in stock awards, $3.4 million in stock options, and $3.4 million in pension and other compensation.

What is Richard Gonzalez’s email address?

Richard Gonzalez’s former corporate email address at AbbVie was [email protected]. Since he has retired from the company, this email may no longer be active. He can be reached via LinkedIn. AbbVie’s current CEO Robert A. Michael can be contacted through the company’s corporate office.

Why did Richard Gonzalez retire from AbbVie?

AbbVie announced in February 2024 that Gonzalez would step down as CEO effective July 1, 2024 as part of a planned succession. Having led the company for over 11 years, Gonzalez transitioned to the Executive Chairman role before fully departing the board in July 2025. He selected longtime deputy Robert A. Michael as his successor, ensuring continuity of AbbVie’s strategic direction.

Article last updated:February 2026March 2, 2026